Long‐term follow‐up in dogs with idiopathic eosinophilic bronchopneumopathy treated with inhaled steroid therapy
Authors:
- 28 July 2016
- journal article
- clinical trial
- Published by Wiley in Journal of Small Animal Practice
- Vol. 57 (10) , 537-542
Abstract
Treatment of canine idiopathic eosinophilic bronchopneumopathy mainly consists of long-term oral corticosteroid therapy. To avoid side effects, inhaled steroid therapy has been increasingly used but long-term clinical response and potential side effects are sparsely described. Description of clinical response and side effects with long-term fluticasone in dogs with eosinophilic bronchopneumopathy. Case series of dogs with eosinophilic bronchopneumopathy and treated with fluticasone monotherapy for at least 6 months. Clinical response and side effects assessed by physical examination, standardised questionnaire and ACTH (corticotropin) stimulation test. Eight dogs were treated for between 6 months and 5 years. Cough initially improved in all dogs; two dogs remained free of clinical signs, three were well controlled, but three showed severe relapse. Pituitary-adrenal axis inhibition occurred in two dogs treated with fluticasone monotherapy for more than 2 years; only one dog had clinical signs of iatrogenic hyperadrenocorticism. Fluticasone monotherapy allows initial improvement or remission in the majority of dogs but long-term treatment fails to resolve the cough in some individuals. In addition, such therapy may induce pituitary-adrenal axis inhibition. Prospective larger and randomised studies including both fluticasone and orally-treated dogs are needed to define the optimal treatment.Keywords
This publication has 26 references indexed in Scilit:
- An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary diseaseInternational Journal of Chronic Obstructive Pulmonary Disease, 2010
- Effects of fluticasone propionate dosage in an experimental model of feline asthmaJournal of Feline Medicine and Surgery, 2010
- A longitudinal assessment of the effect of inhaled fluticasone propionate therapy on adrenal function and growth in young children with asthmaPediatric Pulmonology, 2008
- Endocrine and Immunologic Effects of Inhaled Fluticasone Propionate in Healthy DogsJournal of Veterinary Internal Medicine, 2008
- Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstrictionBritish Journal of Clinical Pharmacology, 2007
- Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthmaBritish Journal of Clinical Pharmacology, 2006
- Management of 13 cases of canine respiratory disease using inhaled corticosteroidsJournal of Small Animal Practice, 2006
- Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysisEuropean Respiratory Journal, 2006
- Eosinophilic Bronchopneumopathy in DogsJournal of Veterinary Internal Medicine, 2000
- Pulmonary infiltration with eosinophils in 14 dogsJournal of Small Animal Practice, 1991